Anti-PD-1 (Pembrolizumab) Biotinylated Antibody

Anti-PD-1 (Pembrolizumab) Biotinylated Antibodyis available at Gentaur for Next week Delivery.

Description: Pembrolizumab (Keytruda) is a humanized monoclonal antibody that is approved by the U.S. Food and Drug Administration for the treatment of patients with unresectable or metastatic melanoma. Pembrolizumab binds to the human cell surface receptor PD-1 (Programmed Cell Death Protein 1) and blocks its interaction with PD-L1, resulting in the activation of T-cell-mediated immune responses against tumor cells.

Immunogen Sequence:Human programmed cell death 1 receptor (PD-1)

Target Alternative Name:/

Species Reactivities:Human

Tag Line:Affinity purified recombinant monoclonal antibody to detect biotinylation of PD-1 in human samples

Formulation:In PBS, 30% glycerol, 0.5% BSA, 0.5 mM EDTA and 0.03% proclin, pH 7.2

Purification: Affinity purified

Application:ELISA

Positive Control:/

Application And Usages:ELISA 0.5 - 1 µg/ml

Handling:The antibody solution should be gently mixed before use.